OPR - Delayed Quote • USD HLTH Sep 2024 7.500 call (HLTH240920C00007500) Follow 0.0400 0.0000 (0.00%) As of March 6 at 3:01 PM EST. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for HLTH240920C00007500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: HLTH Cue Health Announces Strategic Actions to Position Company for Next Stage 3 Promising Penny Stocks You Can Pick Up for Less Than a Quarter Cue Health Inc. (NASDAQ:HLTH) Q4 2023 Earnings Call Transcript Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates Cue Health Reports Fourth Quarter 2023 Financial Results Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results Cue Health Announces Appointment of Rishi Reddy to Board of Directors Cue Health axes more jobs amid declining test sales Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Cue Health (NASDAQ:HLTH) Will Have To Spend Its Cash Wisely Cue Health Inc. (NASDAQ:HLTH) Not Doing Enough For Some Investors As Its Shares Slump 28% Acon receives first FDA clearance for over-the-counter COVID-19 antigen test
